Jefferies Financial Group Brokers Lift Earnings Estimates for MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF)

MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAFGet Rating) – Equities researchers at Jefferies Financial Group lifted their FY2024 earnings per share estimates for shares of MERCK Kommanditgesellschaft auf Aktien in a report released on Thursday, September 15th. Jefferies Financial Group analyst P. Welford now forecasts that the company will post earnings of $11.83 per share for the year, up from their previous forecast of $11.01. The consensus estimate for MERCK Kommanditgesellschaft auf Aktien’s current full-year earnings is $10.61 per share.

MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAFGet Rating) last released its quarterly earnings results on Thursday, August 4th. The company reported $2.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.28. The business had revenue of $5.93 billion during the quarter, compared to the consensus estimate of $5.49 billion. MERCK Kommanditgesellschaft auf Aktien had a return on equity of 17.28% and a net margin of 15.80%.

MERCK Kommanditgesellschaft auf Aktien Trading Down 1.4 %

MERCK Kommanditgesellschaft auf Aktien stock opened at $167.00 on Monday. The business has a 50-day simple moving average of $179.49 and a two-hundred day simple moving average of $184.34. The company has a market cap of $21.58 billion, a P/E ratio of 16.97 and a beta of 0.96. MERCK Kommanditgesellschaft auf Aktien has a 52-week low of $162.20 and a 52-week high of $264.40. The company has a quick ratio of 0.82, a current ratio of 1.28 and a debt-to-equity ratio of 0.36.

About MERCK Kommanditgesellschaft auf Aktien

(Get Rating)

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology.

Read More

Earnings History and Estimates for MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF)

Receive News & Ratings for MERCK Kommanditgesellschaft auf Aktien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MERCK Kommanditgesellschaft auf Aktien and related companies with MarketBeat.com's FREE daily email newsletter.